FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

FDA notes Actelion's supplemental NDA for Tracleer (bosentan) and the agency's approval of the supplemental application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

SUPPL AP for TRACLEER (BOSENTAN)